News

Inhalation of a non-sterile product with microbial contamination into the airways could increase the risk of respiratory infection. The risk is higher in patients who are immunocompromised (because

Tekmira today reported that: Enrolment of the target patient numbers in these Phase I/II studies has been completed; To date, 55 patients, in the both the Phase I

This study assesses a drug’s risk of QT prolongation and its proarrhythmic potential, and is a standard component of all clinical development programs for new molecular entities. Pyridorin

HPP is a genetic, chronic and progressive ultra-rare metabolic disease that can lead to destruction and deformity of bones, profound muscle weakness, seizures, respiratory failure and premature death.1-5

These countries include Bulgaria, the Czech Republic, Hungary, Poland, Romania, Slovakia and Slovenia. With this distributorship in place, Iclusig will be available to patients with resistant and intolerant

As part of the deal, Knight will pay around $1.75m cash as well as offer additional funding to further develop new pharmaceutical products. The deal will see establishment

Amitiza is a prostone and a locally acting chloride channel activator indicated in the US to treat CIC and OIC in adults. The company said that the effectiveness

Bekinda (RHB-102) is a proprietary once-daily oral pill formulation of the antiemetic drug ondansetron. The UK MHRA has started the formal review process for the MAA on 30

The agreement granted Takeda exclusive rights to market ferumoxytol in Canada, EU and Switzerland, as well as certain other geographic territories As part of the termination deal, AMAG